Use of Ovatodiolide against SARS-CoV-2
US-12403125-B2 · Sep 2, 2025 · US
This page is not indexed by search engines while we improve data quality.
Cns Biotek Corp patents
Cns Biotek Corp holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 3 |
| First publication | May 11, 2023 |
| Latest publication | Sep 2, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Use of anisomelic acid in preparation of pharmaceutical composition for inhibiting infection and replication of sars-cov-2 and variants
US-2024408055-A1 · Dec 12, 2024 · US
A method for asymmetric synthesis of (-)- Anisomelic Acid
US-2024287013-A1 · Aug 29, 2024 · US
Use of Ovatodiolide against SARS-CoV-2
US-2023143813-A1 · May 11, 2023 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Use of Ovatodiolide against SARS-CoV-2
US-12403125-B2 · Sep 2, 2025 · US
Use of anisomelic acid in preparation of pharmaceutical composition for inhibiting infection and replication of sars-cov-2 and variants
US-2024408055-A1 · Dec 12, 2024 · US
A method for asymmetric synthesis of (-)- Anisomelic Acid
US-2024287013-A1 · Aug 29, 2024 · US
Use of Ovatodiolide against SARS-CoV-2
US-2023143813-A1 · May 11, 2023 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 1 |
| Cross-Sectional Technologies | 1 |